Issue Type: R&D Investment Prioritizes Profitability Over Public Health and Innovation
in challenge narrative
-
Evaluating Industry’s Drug Pricing Claims
-
Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle
-
After 4 Years of Trump, Medicare and Medicaid Badly Need Attention
-
Profitability over Public Health and Innovation
-
Incentives for Rare Diseases: the Right Healthcare Priorities?
-
Time to Throw in the Towel on Biosimilars
-
DPL and Collaborators to Publish Drug Pricing Primer Series
-
Billion-Dollar Babies
-
Is Profit or Innovation Driving the Rising Costs of Drugs?
-
Dr. Peter Bach Explains How Increasing Drug Prices Stifles Innovation